[Federal Register Volume 75, Number 43 (Friday, March 5, 2010)]
[Notices]
[Pages 10312-10313]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-4770]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances Notice of Registration

    By Notice dated October 21, 2009, and published in the Federal 
Register on October 28, 2009 (74 FR 55584), Hospira Inc., 1776 North 
Centennial Drive, McPherson, Kansas 67460-1247, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of Remifentanil (9739), a basic class of controlled 
substance listed in schedule II.
    The company plans to import Remifentanil for use in dosage form 
manufacturing.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Hospira Inc. to import the basic class of controlled 
substance is consistent with the public interest, and with United 
States obligations under international

[[Page 10313]]

treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Hospira Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 
1301.34, the above named company is granted registration as an importer 
of the basic class of controlled substance listed.

    Dated: February 26, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-4770 Filed 3-4-10; 8:45 am]
BILLING CODE 4410-09-P